A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Calprotectin in Viral Systemic Infections- COVID-19 Versus Hepatitis C Virus
PurposeThis study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. MethodsThis observational study was performed between April 2020 and October 2020 in a single Internal Medicine center. We determined serum and fecal calprotectin, as well as levels of transaminases, C-reactive protein, ferritin, in 25 patients with COVID-19 infection, 30 patients with active HCV chronic infection anddoi:10.21203/rs.3.rs-497871/v1 fatcat:cozzymz7hjbvxplht6rpb4vvxy